Instituto de Câncer E Transplante

Curitiba, Paraná 80510-130

0 studies enrolling now · 1 studies all time

What they study most

HER2-Positive Early Breast Cancer

Studies at this site

• A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer — Completed